These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A comparative crossover study on the treatment of hemifacial spasm and blepharospasm: preseptal and pretarsal botulinum toxin injection techniques. Lolekha P; Choolam A; Kulkantrakorn K Neurol Sci; 2017 Nov; 38(11):2031-2036. PubMed ID: 28884242 [TBL] [Abstract][Full Text] [Related]
5. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm. Cakmur R; Ozturk V; Uzunel F; Donmez B; Idiman F J Neurol; 2002 Jan; 249(1):64-8. PubMed ID: 11954870 [TBL] [Abstract][Full Text] [Related]
6. Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm. Bentivoglio AR; Fasano A; Ialongo T; Soleti F; Lo Fermo S; Albanese A Eur J Neurol; 2009 Mar; 16(3):392-8. PubMed ID: 19364366 [TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm. Ababneh OH; Cetinkaya A; Kulwin DR Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601 [TBL] [Abstract][Full Text] [Related]
8. Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm. Wu CJ; Shen JH; Chen Y; Lian YJ Turk Neurosurg; 2011; 21(4):625-9. PubMed ID: 22194126 [TBL] [Abstract][Full Text] [Related]
9. [Safety and efficacy of botulinum toxin in hemifacial spasm]. Mazlout H; Kamoun Gargouri H; Triki W; Kéfi S; Brour J; El Afrit MA; Chéour M; Kraiem A J Fr Ophtalmol; 2013 Mar; 36(3):242-6. PubMed ID: 23270989 [TBL] [Abstract][Full Text] [Related]
10. Comparison of preseptal and pretarsal onabotulinum toxin an injection in patients with hemifacial spasm. Yılmaz ATC; Yılmaz M; Öztekin MF Int J Neurosci; 2021 Jun; 131(6):549-554. PubMed ID: 32233985 [TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study. Defazio G; Abbruzzese G; Girlanda P; Vacca L; Currà A; De Salvia R; Marchese R; Raineri R; Roselli F; Livrea P; Berardelli A Arch Neurol; 2002 Mar; 59(3):418-20. PubMed ID: 11890846 [TBL] [Abstract][Full Text] [Related]
12. Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study. Kongsengdao S; Kritalukkul S J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S48-54. PubMed ID: 22619887 [TBL] [Abstract][Full Text] [Related]
13. Increasing the area and varying the dosage of Botulinum toxin a injections for effective treatment of hemifacial spasm. Choe WJ; Kim J Acta Otolaryngol; 2016 Sep; 136(9):952-5. PubMed ID: 27067535 [TBL] [Abstract][Full Text] [Related]
14. Routine use of Xeomin in patients previously treated with Botox: long term results. Dressler D Eur J Neurol; 2009 Dec; 16 Suppl 2():2-5. PubMed ID: 20002739 [TBL] [Abstract][Full Text] [Related]
15. Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections. Price J; Farish S; Taylor H; O'Day J Ophthalmology; 1997 May; 104(5):865-8. PubMed ID: 9160036 [TBL] [Abstract][Full Text] [Related]
16. Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm. Cannon PS; MacKenzie KR; Cook AE; Leatherbarrow B Clin Exp Ophthalmol; 2010 Oct; 38(7):688-91. PubMed ID: 20456439 [TBL] [Abstract][Full Text] [Related]
17. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm. Bihari K Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212 [TBL] [Abstract][Full Text] [Related]
19. Treatment of hemifacial spasm with botulinum toxin. Kobayashi T; Sugasawa K; Ishii K; Takeuchi N Eur Arch Otorhinolaryngol; 1994 Dec; ():S193-4. PubMed ID: 10774348 [No Abstract] [Full Text] [Related]
20. Evaluation of stigmatization in hemifacial spasm and quality of life before and after botulinum toxin treatment. Yuksel B; Genc F; Yaman A; Goksu EO; Ak PD; Gomceli YB Acta Neurol Belg; 2019 Mar; 119(1):55-60. PubMed ID: 30178181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]